Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Renal Cell × Ipilimumab × Clear all

Phase

Status

Recruiting 16 Completed 16 Active not recruiting 13 Terminated 5 Unknown 2 Withdrawn 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Turcot syndrome 1 Sarcoma 1 Post-Acute COVID-19 Syndrome 1 Liver Neoplasms 1 Kidney Neoplasms 1 Fibrolamellar hepatocellular carcinoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Kidney Cancer 1

Interventions

Specimen Handling 4 pembrolizumab 3 lenvatinib 3 Nivolumab 3 vorolanib 2 palbociclib 2 cabozantinib 2 belzutifan 2 Sunitinib 2 Biopsy 2 Axitinib 2 zimberelimab 1 tivozanib 1 sodium pentaborate 1 sintilimab 1 pazopanib 1 fludarabine 1 bemarituzumab 1 anlotinib 1 Zoledronic Acid 1 Watchful Waiting 1 Saline Solution 1 Rubidium-82 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Pluvicto 1 Nephrectomy 1 Ipilimumab 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07233668 2025-12-03

IVE in mRCC

Seoul National University Hospital

Phase NA Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡